Representing Private Equity Sponsors in Healthcare Transactions: Best Practices for Due Diligence


Wednesday, April 10, 2013



Geoffrey C. Cockrell and Amber McGraw Walsh, McGuireWoods LLP; Laura Keidan Martin, Katten Muchin Rosenman LLP

RSVP: or (800) 253-6397




12:30-2 pm EST

CLE Credits:

1.5-1.8 hrs


Without the infusion of private equity funds, many hospitals would not have the resources to continue operating. However, using private equity funds to finance healthcare transactions presents many regulatory and transactional issues. Such issues could potentially be avoided with thorough due diligence including investigating a target company’s operations; identifying potential regulatory and legal risks that may affect investment returns; and helping clients correct potential issues and suggesting alternative deal structures.